Monsanto Company (MON) Stake Decreased by Oliver Luxxe Assets LLC
Oliver Luxxe Assets LLC cut its stake in Monsanto Company (NYSE:MON) by 9.1% during the first quarter, Holdings Channel reports. The fund owned 1,996 shares of the basic materials company’s stock after selling 200 shares during the period. Oliver Luxxe Assets LLC’s holdings in Monsanto Company were worth $226,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Strs Ohio increased its position in Monsanto Company by 4.3% in the third quarter. Strs Ohio now owns 285,114 shares of the basic materials company’s stock valued at $29,138,000 after buying an additional 11,861 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its position in Monsanto Company by 30.7% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,619,635 shares of the basic materials company’s stock valued at $165,527,000 after buying an additional 379,975 shares in the last quarter. Meridian Management Co. increased its position in Monsanto Company by 0.5% in the third quarter. Meridian Management Co. now owns 22,003 shares of the basic materials company’s stock valued at $2,249,000 after buying an additional 103 shares in the last quarter. Country Trust Bank increased its position in Monsanto Company by 71.6% in the third quarter. Country Trust Bank now owns 221,268 shares of the basic materials company’s stock valued at $22,614,000 after buying an additional 92,302 shares in the last quarter. Finally, Sandy Spring Bank increased its position in Monsanto Company by 1.0% in the third quarter. Sandy Spring Bank now owns 23,299 shares of the basic materials company’s stock valued at $2,382,000 after buying an additional 220 shares in the last quarter. 75.18% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company (NYSE:MON) traded down 0.20% during mid-day trading on Tuesday, hitting $115.96. 332,538 shares of the company were exchanged. Monsanto Company has a 12-month low of $88.76 and a 12-month high of $116.60. The company has a market capitalization of $50.88 billion, a P/E ratio of 26.68 and a beta of 0.93. The company’s 50-day moving average is $114.37 and its 200 day moving average is $107.20.
Monsanto Company (NYSE:MON) last posted its earnings results on Wednesday, April 5th. The basic materials company reported $3.19 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.40. The firm had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Monsanto Company had a net margin of 11.61% and a return on equity of 47.05%. The company’s revenue was up 12.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.42 earnings per share. Analysts expect that Monsanto Company will post $4.90 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, April 7th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, April 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.86%. Monsanto Company’s payout ratio is presently 58.86%.
COPYRIGHT VIOLATION WARNING: “Monsanto Company (MON) Stake Decreased by Oliver Luxxe Assets LLC” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/04/18/monsanto-company-mon-stake-decreased-by-oliver-luxxe-assets-llc.html.
MON has been the topic of several research reports. Vetr downgraded Monsanto Company from a “buy” rating to a “hold” rating and set a $118.00 price objective on the stock. in a report on Tuesday, March 7th. Zacks Investment Research downgraded Monsanto Company from a “buy” rating to a “hold” rating in a report on Monday, January 9th. Royal Bank of Canada initiated coverage on Monsanto Company in a report on Thursday, February 23rd. They set a “sector perform” rating and a $118.00 price objective on the stock. CLSA raised Monsanto Company from an “underperform” rating to an “outperform” rating in a report on Friday, January 6th. They noted that the move was a valuation call. Finally, Sanford C. Bernstein set a $105.00 price objective on Monsanto Company and gave the stock a “neutral” rating in a report on Thursday, January 5th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $118.94.
In other Monsanto Company news, CEO Hugh Grant sold 149,230 shares of the business’s stock in a transaction on Monday, April 10th. The shares were sold at an average price of $116.15, for a total transaction of $17,333,064.50. Following the sale, the chief executive officer now owns 390,373 shares of the company’s stock, valued at $45,341,823.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Steven Mizell sold 13,700 shares of the business’s stock in a transaction on Monday, April 10th. The stock was sold at an average price of $116.11, for a total transaction of $1,590,707.00. Following the sale, the executive vice president now directly owns 50,295 shares in the company, valued at approximately $5,839,752.45. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 168,600 shares of company stock worth $19,547,472. Insiders own 0.79% of the company’s stock.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.